Ben Lamm
Area of Focus
Ben Lamm works in the fields of genetic engineering, biotechnology, and artificial intelligence, focusing on de-extinction, conservation biology, and synthetic biology.
Born
Not available.
Citizenship
United States.
Education
Lamm attended Baylor University.
Occupations
Ben Lamm is an entrepreneur and the founder of several companies, including Colossal Biosciences, Form Bio, Breaking, and Astromech.
Career & Projects
Lamm founded Colossal Biosciences in 2021 to advance genetic engineering and reproductive technology, with the goal of de-extinction. The company has raised over $615 million to apply CRISPR technology to conservation biology, specifically targeting the revival of the woolly mammoth and the dire wolf. In 2024, he launched The Colossal Foundation to support global conservation efforts, including the Colossal BioVault.
Lamm also co-founded Form Bio in 2022 to develop software for scientific efficiency and launched the synthetic biology startup Breaking in 2024, which discovered a microbe capable of degrading plastics. His current work includes operating the AI startup Astromech, which is developing a forecasting engine for biological outcomes, and serving on the UAP Science Advisory Council as of 2026.
Vision for the Future
Lamm aims to utilize advanced genetic and synthetic biology technologies to address environmental and biological challenges. His stated goals include the de-extinction of species such as the woolly mammoth and the dire wolf, as well as the development of biological solutions for plastic degradation and scientific forecasting.